Type 2 diabetes is an individual health challenge requiring constant self-management. Remote patient reporting of relevant health parameters and linked automated feedback via mobile telephone have potential to strengthen self-management and improve outcomes. This research involved development and evaluation of a mobile telephone-based remote patient reporting and automated telephone feedback system, guided by health behaviour change theory, aimed at improving self-management and health status in individuals with type 2 diabetes.
Mobile telephone-based assistance technology was tested in a randomized controlled trial. Inclusion criteria were diagnosis of type 2 diabetes, elevated glycosylated hemoglobin (HbA1c) levels (range, 6.5–11%) or use of oral diabetes medication, and 30–70 years of age. Intervention subjects (n = 24) participated in remote patient reporting of health status parameters and linked health behaviour change feedback. Control participants (n = 24) received standard of care including diabetes education and healthcare provider counselling. Study participants were followed for approximately 10 months. Intervention participants achieved a significantly greater mean reduction in HbA1c of (- 0.40% versus 0.03%) and weight (- 2.1 kg versus 0.4 kg).
Non-significant trends for greater improvements in systolic and diastolic blood pressure were observed in intervention group compared to control group. This research involved development and evaluation of a mobile telephone-based remote patient reporting and automated telephone feedback system. Guided by health behaviour change theory, the study succeeded to improve self-management and health status of individuals with type 2 diabetes.
For more information:
Orsama A-L, Lähteenmäki J, Harno K, Kulju M, Wintergerst E, Schachner H, Stenger P, Leppänen J, Kaijanranta H, Salaspuro V, Fisher W A. Active Assistance Technology Reduces Glycosylated Hemoglobin and Weight in Individuals With Type 2 Diabetes: Results of a Theory-Based Randomized Trial. Diabetes Technology & Therapeutics 2013.
NOTE: You can order a copy of the article by sending the reference to firstname.lastname@example.org